R. Tao

发表

Extensive MET alterations confer clinical response to MET inhibitors in gliomas

Qianghu Wang, T. Jiang, Z. Wang, 2020 .

Phase II Study of High-Dose Pemetrexed Plus Cisplatin as First-Line Chemotherapy In the Treatment of Patients with Brain Metastases from Lung Adenocarcinoma.

Yong Wang, Qiaowei He, R. Tao, 2017, World neurosurgery.

Successful treatment of an adult patient with diffuse midline glioma employing olaparib combined with bevacizumab

Yong Wang, R. Tao, Chuang Qi, 2021, Investigational New Drugs.

Comprehensive identification of FGFR1-4 alterations in 5 557 Chinese patients with solid tumors by next-generation sequencing.

Yong Wang, Xuchao Zhang, Furong Du, 2021, American journal of cancer research.

Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3-TACC3 Fusion and Recurrent Glioblastoma.

Yongsheng Gao, Yong Wang, Henghui Zhang, 2020, The oncologist.

Apatinib (YN968D1) and temozolomide in recurrent invasive pituitary adenoma: case report and literature review.

Xiangjiao Meng, Yong Wang, Qiaowei He, 2019, World neurosurgery.

Potential 18F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and Chemoradiotherapy

Jinming Yu, Z. Fu, Wanhu Li, 2022, Frontiers in Oncology.

Apatinib in recurrent anaplastic meningioma: a retrospective case series and systematic literature review

Xiangjiao Meng, Yong Wang, Yu-fang Zhu, 2020, Cancer biology & therapy.

Phase II Study of the Efficacy and Safety of High-dose Pemetrexed in Combination with Cisplatin Versus Temozolomide for the Treatment of Non-small Cell Lung Cancer with Brain Metastases.

Yong Wang, Qiaowei He, X. Bi, 2017, Anticancer research.

Pemetrexed plus rituximab as second-line treatment for primary central nervous system lymphoma

J. Chen, Haixia Zhao, Jing Tian, 2014, Medical Oncology.

A rare NF1 gene mutation in a Chinese patient with neurofibromatosis type 1 and anaplastic astrocytoma.

S. Yuan, Yu-fang Zhu, R. Tao, 2020, World neurosurgery.

MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitors

Qianghu Wang, Tao Jiang, D. Nam, 2022, Holistic Integrative Oncology.

Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study

Yong Wang, R. Tao, Jun Xu, 2017, OncoTargets and therapy.

Response to: Extraventricular neurocytoma of the sellar region

Yong Wang, R. Tao, Baoyan Liu, 2013, British journal of neurosurgery.

MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A

Q. Pang, Guan Sun, R. Tao, 2011, Oncology reports.

MicroRNA-370 suppresses the progression and proliferation of human astrocytoma and glioblastoma by negatively regulating β-catenin and causing activation of FOXO3a.

Yong Wang, Jing Li, R. Tao, 2017, Experimental and therapeutic medicine.

Stripping surgery in facial nerve schwannomas with favorable facial nerve function.

R. Tao, Daowen Wang, Yi Sun, 2015, American journal of otolaryngology.

Genetic Testing and Immunotherapy for Intracranial Inflammatory Myofibroblastic Tumor: A Case Report

Yong Wang, R. Tao, Jimin Chen, 2022, OncoTargets and therapy.

Phase II trial of temozolomide plus concurrent whole-brain radiation followed by TNV regimen as adjuvant therapy for patients with newly diagnosed primary CNS lymphoma.

Yong Wang, R. Tao, Haitao Zhao, 2013, Neurology India.

Can an 18F-ALF-NOTA-PRGD2 PET/CT Scan Predict Treatment Sensitivity to Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma?

Jinming Yu, Wei Zhao, S. Yuan, 2016, The Journal of Nuclear Medicine.

Hand-Schüller-Christian disease associated with symptomatic cavum septi pellucidi cyst in an adult with a 10-year follow-up.

Yong Wang, R. Tao, Li Li, 2014, World Neurosurgery.

OTT_A_343562 313..321

Yong Wang, R. Tao, Jimin Chen, 2022 .

The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer

X. Qin, S. Yuan, Yong Wang, 2022, Journal of Cancer Research and Clinical Oncology.

Durable Effect of Pyrotinib and Metronomic Vinorelbine in HER2-Positive Breast Cancer With Leptomeningeal Disease: A Case Report and Literature Review

Li′ang Xu, R. Tao, Binbin Cong, 2022, Frontiers in Oncology.

The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer

X. Qin, S. Yuan, Yong Wang, 2022, Journal of Cancer Research and Clinical Oncology.

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study

Xiangjiao Meng, Yong Wang, R. Tao, 2019, OncoTargets and therapy.

OTT_A_226804 10579..10585

Xiangjiao Meng, Yong Wang, R. Tao, 2019 .

The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Previously Treated Advanced Thymic Epithelia Tumors: A Retrospective Analysis

Hui Zhang, R. Tao, Xi-qin Zhang, 2022, Recent patents on anti-cancer drug discovery.

Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R Mutation

Hui Zhang, R. Tao, Dongyuan Zhu, 2023, The oncologist.

Olaparib Combined With Dacomitinib in Osimertinib-Resistant Brain and Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Report and Systematic Review

Xiangjiao Meng, Yong Wang, R. Tao, 2022, Frontiers in Oncology.

The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Previously Treated Advanced Thymic Epithelia Tumors: A Retrospective Analysis

Hui Zhang, R. Tao, Xi-qin Zhang, 2022, Recent patents on anti-cancer drug discovery.